← FDA DRUG APPROVALS
FDA NDA · NDA020183
DIANEAL LOW CALCIUM WITH DEXTROSE
sodium chloride, sodium lactate, calcium chloride, magnesium chloride and dextrose
Sponsor: VANTIVE US HLTHCARE
APPLICATION
NDA020183
TYPE
NDA
ORIGINAL APPROVAL
1992-12-04
LATEST ACTION
2023-06-05
ROUTE
INTRAPERITONEAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription, Discontinued
Products
DIANEAL LOW CALCIUM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER · ReferencePrescription
CALCIUM CHLORIDE 18.3MG/100ML, DEXTROSE 4.25GM/100ML, MAGNESIUM CHLORIDE 5.08MG/100ML, SODIUM CHLORIDE 538MG/100ML, SODIUM LACTATE 448MG/100ML · SOLUTION · INTRAPERITONEAL
DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER · ReferencePrescription
CALCIUM CHLORIDE 18.3MG/100ML, DEXTROSE 2.5GM/100ML, MAGNESIUM CHLORIDE 5.08MG/100ML, SODIUM CHLORIDE 538MG/100ML, SODIUM LACTATE 448MG/100ML · SOLUTION · INTRAPERITONEAL
DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER · ReferenceDiscontinued
CALCIUM CHLORIDE 18.3MG/100ML, DEXTROSE 3.5GM/100ML, MAGNESIUM CHLORIDE 5.08MG/100ML, SODIUM CHLORIDE 538MG/100ML, SODIUM LACTATE 448MG/100ML · SOLUTION · INTRAPERITONEAL
DIANEAL LOW CALCIUM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER · ReferencePrescription
CALCIUM CHLORIDE 18.3MG/100ML, DEXTROSE 1.5GM/100ML, MAGNESIUM CHLORIDE 5.08MG/100ML, SODIUM CHLORIDE 538MG/100ML, SODIUM LACTATE 448MG/100ML · SOLUTION · INTRAPERITONEAL
Approval history
2014-09-30Manufacturing (CMC) · Supplement 23 · standardAP
2013-04-26Manufacturing (CMC) · Supplement 22 · standardAP
2002-02-12Manufacturing (CMC) · Supplement 7 · standardAP
2001-08-22Manufacturing (CMC) · Supplement 6 · standardAP
1997-04-29Manufacturing (CMC) · Supplement 5 · standardAP
1996-11-22Manufacturing (CMC) · Supplement 4 · standardAP
1994-09-30Manufacturing (CMC) · Supplement 1 · standardAP
1994-06-01Manufacturing (CMC) · Supplement 3 · standardAP
1994-02-18Manufacturing (CMC) · Supplement 2 · standardAP
1992-12-04Type 5 - New Formulation or New Manufacturer · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.